首页> 外文期刊>Saudi Pharmaceutical Journal >Pharmacists' and physicians' perception and exposure to drug promotion: A Saudi study
【24h】

Pharmacists' and physicians' perception and exposure to drug promotion: A Saudi study

机译:药剂师和医师对药物促销的看法和接触:沙特的一项研究

获取原文
           

摘要

Introduction: Drug promotion has to contribute to a more rational use of drugs. Concerns arise if promotion negatively influences prescribing/dispensing pattern. It is warranted to assess exposure and attitudes to, and acceptance of, drug promotion among pharmacists and physicians. Methodology: Adopting a randomized, multiple site and cross-sectional survey study, questionnaires (n=250) were completed by physicians and pharmacists to investigate the exposure, acceptance or skepticism of Saudi physicians/pharmacists to drug promotion as well as their perception of the appropriateness of gifts and to check if they had any teaching/training about dealing with medical representatives (MRs) and Pharma promotion. Results: Significantly more pharmacists than physicians (32% vs. 23%; p0.05) reported being taught or educated about the ethics of drug promotion. The experience level was significantly associated with the teaching or training that the physicians and pharmacists received. Conference registration fees and drug samples were the most appropriate promotional gift for the physicians (67% and 66%, respectively; p0.01) whereas for pharmacists, the drug sample was considered the most suitable donation (79%). More pharmacists perceived drug companies as a useful way to gain knowledge about drugs than physicians (75% vs. 65%; p0.01). A higher proportion of both groups were accepting drug promotion than those skeptical about it. Conclusion: The majority of physicians or pharmacists participating in this study have received gifts from pharmaceutical companies. The drug samples and printed educational materials are the most widely accepted gifts. Recent graduates and those with few years of experience had higher teaching/training than experienced physicians and pharmacists in pharmaceutical promotion ethics and tactics to deal with MRs. On the other hand, experienced healthcare team were more approached and targeted by pharmaceutical companies and MRs. It is highly recommended to implement courses/discussion groups on the ethical interaction between healthcare professionals and pharmaceutical companies in the curriculum of both pharmacy and medicine. Updating the physicians and pharmacists after graduation, as part of continued medical/pharmacy education, will eventually improve the healthcare professionals' capability to act to the patients' welfare.
机译:简介:毒品宣传必须有助于更合理地使用毒品。如果促销对处方/配药方式产生负面影响,则会引起担忧。保证评估药剂师和医生对药物推广的接触,态度和接受程度。方法:采用随机,多地点和横断面调查研究,由医师和药剂师填写问卷(n = 250),以调查沙特医师/药剂师对药物推广的接触,接受或怀疑,以及他们对药物促销的看法。礼物的适当性,并检查他们是否有任何与医学代表打交道和药品促销的教学/培训。结果:据报告,接受过有关药物推广道德规范的教育或教育的药剂师比医生多(32%比23%; p <0.05)。经验水平与医师和药剂师接受的教学或培训显着相关。会议注册费和药品样本是最适合医生的促销礼物(分别为67%和66%; p <0.01),而对于药剂师来说,药品样本被认为是最合适的捐赠(79%)。与医生相比,更多的药剂师认为药品公司是获得有关药品知识的有用途径(75%比65%; p <0.01)。两组中接受药物推广的比例高于对此持怀疑态度的人群。结论:参加这项研究的大多数医师或药剂师都收到了制药公司的礼物。药物样品和印刷的教学材料是最广泛接受的礼物。与应届毕业生相比,应届毕业生和具有几年经验的毕业生在药物推广道德和应对MR的策略方面,比经验丰富的医师和药剂师具有更高的教学/培训水平。另一方面,制药公司和MR会更接近并有经验的医疗团队。强烈建议在药房和医学课程中实施有关医疗保健专业人员和制药公司之间的道德互动的课程/讨论小组。毕业后更新医师和药剂师,作为持续医学/药学教育的一部分,最终将提高医疗保健专业人员对患者的福利采取行动的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号